Inclusion of transgender and gender diverse health data in cancer biorepositories

Nat C. Jones; Amy K. Otto; Dana E. Ketcher; Jennifer B. Permuth; Gwendolyn P. Quinn; Matthew B. Schabath

doi:10.1016/j.conctc.2020.100597

Inclusion of transgender and gender diverse health data in cancer biorepositories

Nat C. Jones, Amy K. Otto, Dana E. Ketcher, Jennifer B. Permuth, Gwendolyn P. Quinn, Matthew B. Schabath

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Biobanks have the potential to be robust resource for understanding potential cancer risks associated with gender-affirming interventions. In this narrative review, we synthesized the current published literature regarding the inclusion of TGD health data in cancer biorepositories and cancer research conducted on biospecimens. Of the 6986 initial results, 153 (2.2%) assessed the biological effects of gender-affirming interventions on TGD tissues. Within that category, only one paper examined transgender tissues in relation to cancer biobanks. Strategies are offered to address the inequities in TGD tissue-based research and diversify the field of biobanking as a whole.

Original language	English (US)
Article number	100597
Journal	Contemporary Clinical Trials Communications
Volume	19
DOIs	https://doi.org/10.1016/j.conctc.2020.100597
State	Published - Sep 2020
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2020

Keywords

Biospecimens
LGBT
SGM
Transgender persons

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.conctc.2020.100597

OpenUrl availability

Full text

Cite this

@article{12a4d577827b40ffaf37c8091863183f,

title = "Inclusion of transgender and gender diverse health data in cancer biorepositories",

abstract = "Biobanks have the potential to be robust resource for understanding potential cancer risks associated with gender-affirming interventions. In this narrative review, we synthesized the current published literature regarding the inclusion of TGD health data in cancer biorepositories and cancer research conducted on biospecimens. Of the 6986 initial results, 153 (2.2%) assessed the biological effects of gender-affirming interventions on TGD tissues. Within that category, only one paper examined transgender tissues in relation to cancer biobanks. Strategies are offered to address the inequities in TGD tissue-based research and diversify the field of biobanking as a whole.",

keywords = "Biospecimens, LGBT, SGM, Transgender persons",

author = "Jones, {Nat C.} and Otto, {Amy K.} and Ketcher, {Dana E.} and Permuth, {Jennifer B.} and Quinn, {Gwendolyn P.} and Schabath, {Matthew B.}",

note = "Publisher Copyright: {\textcopyright} 2020",

year = "2020",

month = sep,

doi = "10.1016/j.conctc.2020.100597",

language = "English (US)",

volume = "19",

journal = "Contemporary Clinical Trials Communications",

issn = "2451-8654",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Inclusion of transgender and gender diverse health data in cancer biorepositories

AU - Jones, Nat C.

AU - Otto, Amy K.

AU - Ketcher, Dana E.

AU - Permuth, Jennifer B.

AU - Quinn, Gwendolyn P.

AU - Schabath, Matthew B.

PY - 2020/9

Y1 - 2020/9

N2 - Biobanks have the potential to be robust resource for understanding potential cancer risks associated with gender-affirming interventions. In this narrative review, we synthesized the current published literature regarding the inclusion of TGD health data in cancer biorepositories and cancer research conducted on biospecimens. Of the 6986 initial results, 153 (2.2%) assessed the biological effects of gender-affirming interventions on TGD tissues. Within that category, only one paper examined transgender tissues in relation to cancer biobanks. Strategies are offered to address the inequities in TGD tissue-based research and diversify the field of biobanking as a whole.

AB - Biobanks have the potential to be robust resource for understanding potential cancer risks associated with gender-affirming interventions. In this narrative review, we synthesized the current published literature regarding the inclusion of TGD health data in cancer biorepositories and cancer research conducted on biospecimens. Of the 6986 initial results, 153 (2.2%) assessed the biological effects of gender-affirming interventions on TGD tissues. Within that category, only one paper examined transgender tissues in relation to cancer biobanks. Strategies are offered to address the inequities in TGD tissue-based research and diversify the field of biobanking as a whole.

KW - Biospecimens

KW - LGBT

KW - SGM

KW - Transgender persons

UR - http://www.scopus.com/inward/record.url?scp=85086805125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086805125&partnerID=8YFLogxK

U2 - 10.1016/j.conctc.2020.100597

DO - 10.1016/j.conctc.2020.100597

M3 - Article

C2 - 32613134

AN - SCOPUS:85086805125

SN - 2451-8654

VL - 19

JO - Contemporary Clinical Trials Communications

JF - Contemporary Clinical Trials Communications

M1 - 100597

ER -

Inclusion of transgender and gender diverse health data in cancer biorepositories

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this